Olmesartan Medoxomil Vs. Telmisartan Vs. Atacand Vs. Irbesartan for a male patient aged 53 - from FDA reports


Summary

This is a personalized comparison Olmesartan Medoxomil, Telmisartan, Atacand, Irbesartan for a man aged 53. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>



On Aug, 05, 2017

6,700 males aged 53 (±5) who take Olmesartan Medoxomil, Telmisartan, Atacand, Irbesartan are studied.

Number of reports submitted per year:

Olmesartan Medoxomil, Telmisartan, Atacand, Irbesartan for a male patient aged 53.

Information of the patient in this study:

  • Age: 53
  • Gender: male
  • Reason for the study: Blood Pressure - High

Drugs in this study:

  • Olmesartan Medoxomil (olmesartan medoxomil)
  • Telmisartan (telmisartan)
  • Atacand (candesartan cilexetil)
  • Irbesartan (irbesartan)

eHealthMe real world results for males aged 53 (±5):

Most common side effects:

Olmesartan Medoxomil:
  • Breathing Difficulty
  • Dizziness
  • Drug Ineffective
  • Fatigue
  • Headache
  • Hypotension
  • Nausea
  • Pain
  • Rashes
  • Weakness
Telmisartan:
  • Anaemia
  • Diarrhea
  • Dizziness
  • Drug Ineffective
  • Fatigue
  • Hypotension
  • Nausea
  • Rashes
  • Thrombocytopenia
  • Weakness
Atacand:
  • Chest Pain
  • Diarrhea
  • Dizziness
  • Fever
  • Heart Attack
  • Hypotension
  • Malaise
  • Rashes
  • Renal Failure Acute
  • Weakness
Irbesartan:
  • Breathing Difficulty
  • Chest Pain
  • Dizziness
  • Drug Ineffective
  • Fatigue
  • Heart Attack
  • Nausea
  • Pain
  • Rashes
  • Weakness

Most common side effects experienced by people in long term use:

Olmesartan Medoxomil:
  • Dehydration
  • Diarrhea
  • Diverticulum
  • Drug Ineffective
  • Gastroesophageal Reflux Disease
  • Hiatal Hernia
  • Hypotension
  • Malabsorption
  • Memory Loss
  • Thrombocytopenia
Telmisartan:
  • Allergic Rhinitis
  • Cerebral Infarction
  • Dizziness
  • Hyperhidrosis
  • Hyperkalemia
  • Intervertebral Disc Protrusion
  • Muscle Contractions Involuntary
  • Pleurisy
  • Pulmonary Air Leakage
  • Tremor
Atacand:
  • Cerebral Infarction
  • Chest Pain
  • Dizziness
  • Drug Ineffective
  • Hypotension
  • Loss Of Consciousness
  • Pleural Effusion
  • Renal Failure Acute
  • Rib Fracture
  • Weakness
Irbesartan:
  • Bacteraemia
  • Blood Glucose Increased
  • Breathing Difficulty
  • Death
  • Diabetes
  • Dizziness
  • Heart Attack
  • Musculoskeletal Chest Pain
  • Pancytopenia
  • Pneumonia

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

Related studies:

Can you answer these questions?

More questions for: Olmesartan medoxomil, Telmisartan, Atacand, Irbesartan

You may be interested in these reviews

More reviews for: Olmesartan medoxomil, Telmisartan, Atacand, Irbesartan